TLIS Talis Biomedical Corporation

At Talis, we strive to deliver excellence in point of care diagnostics by increasing access to timely and accurate testing that can help combat the spread of known and emerging infectious diseases.

As of 12/03/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2021
Outstanding shares:  26,288,616
Average volume:  283,989
Market cap:   $120,927,634
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    87424L108
ISIN:        US87424L1089
Sedol:      BLH1HZ6
Valuation   (See tab for details)
PE ratio:   -0.59
PB ratio:   0.47
PS ratio:   0.00
Return on equity:   -80.21%
Net income %:   -1,135,982.05%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy